AstraZeneca Q2 profits up 22 pct
AstraZeneca Q2 profits up 22 pct AstraZeneca PLC posted a 22 percent rise in second quarter net profit on Thursday as it also revealed that a key new drug — its blood thinner Brilinta — has been given a thumbs up by an advisory committee of the U.S. Food and Drug Administration. Read more on [...]